Metabolic and inflammatory functions of cannabinoid receptor type 1 are differentially modulated by adiponectin

BACKGROUND: Antagonists of cannabinoid type 1 receptor (CB1) have been shown to promote body weight loss and improve insulin sensitivity. Cannabinoids decrease adiponectin, and CB1 blocker increase adiponectin. However, the mediators of CB1 actions are not well defined. AIM: To investigate whether t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qiong, Lee, Jong Han, Wu, Chia-Shan, Zang, Qun S, Guo, Shaodong, Lu, Hui-Chen, Sun, Yuxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554371/
https://www.ncbi.nlm.nih.gov/pubmed/34754376
http://dx.doi.org/10.4239/wjd.v12.i10.1750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554371/
https://www.ncbi.nlm.nih.gov/pubmed/34754376
http://dx.doi.org/10.4239/wjd.v12.i10.1750

Ejemplares similares